VERACYTE, INC.
Provides AI-powered genomic tests to guide personalized cancer treatment decisions globally.
VCYT | US
Overview
Corporate Details
- ISIN(s):
- US92337F1075
- LEI:
- Country:
- United States of America
- Address:
- 6000 SHORELINE COURT, SUITE 300, 94080 SOUTH SAN FRANCISCO
- Website:
- https://www.veracyte.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Technical testing and analysis
Description
Veracyte, Inc. is a global diagnostics company specializing in genomic testing and molecular diagnostics for cancer care. The company's Veracyte Diagnostics Platform leverages broad genomic and clinical data with AI-assisted bioinformatics to provide clinicians with high-value, actionable insights. These insights help guide patient treatment decisions, personalize therapy plans, and determine whether to avoid unnecessary medical procedures. Veracyte's portfolio of advanced genomic tests includes the Afirma Genomic Sequencing Classifier, the Decipher Prostate Cancer portfolio, and the Prosigna Breast Cancer Assay, serving patients globally through centralized labs and distributed in-vitro diagnostics (IVDs).
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all VERACYTE, INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for VERACYTE, INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for VERACYTE, INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
